Filed: 2/12/2025ACC: 0001843547-25-000004
📋 What this filing means
VANTAGE CONSULTING GROUP INC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $10.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$10.49M
Total AUM (reported)
4.77M
Total Shares
Allocation by class
COM$10.49M100.0%
Portfolio Concentration
Top 3$8.84M84.2%
4–10$1.66M15.8%
Top 3 weight
84.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.77M
Sole
Full voting authority
4.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
Babcock & Wilcox Enterprises Inc.
SOLEShares2.42M
TypeSH
Market value$3.96M
37.77%
Sole
2.42M
Shared
0.00
None
0.00
Cibus, Inc.
SOLEShares1.14M
TypeSH
Market value$3.18M
30.31%
Sole
1.14M
Shared
0.00
None
0.00
ADC Therapeutics SA
SOLEShares850.74K
TypeSH
Market value$1.69M
16.14%
Sole
850.74K
Shared
0.00
None
0.00
Potbelly Corporation
SOLEShares164.88K
TypeSH
Market value$1.55M
14.80%
Sole
164.88K
Shared
0.00
None
0.00
Fibrogen, Inc
SOLEShares195.71K
TypeSH
Market value$103.6K
0.99%
Sole
195.71K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Babcock & Wilcox Enterprises Inc.SOLE | COM | 2.42M | SH | $3.96M 37.77% | 2.42M | 0.00 | 0.00 |
Cibus, Inc.SOLE | Com | 1.14M | SH | $3.18M 30.31% | 1.14M | 0.00 | 0.00 |
ADC Therapeutics SASOLE | Com | 850.74K | SH | $1.69M 16.14% | 850.74K | 0.00 | 0.00 |
Potbelly CorporationSOLE | COM | 164.88K | SH | $1.55M 14.80% | 164.88K | 0.00 | 0.00 |
Fibrogen, IncSOLE | Com | 195.71K | SH | $103.6K 0.99% | 195.71K | 0.00 | 0.00 |